BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2857613)

  • 1. Effects of desipramine on stimulation-induced contractions of the vas deferens of rats pretreated either chronically with desipramine or acutely with idazoxan.
    Doxey JC; Roach AG; Samuel J
    Clin Sci (Lond); 1985; 68 Suppl 10():155s-159s. PubMed ID: 2857613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC; Roach AG; Strachan DA; Virdee NK
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
    Doxey JC; Roach AG; Smith CF
    Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens.
    Bültmann R; von Kügelgen I; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):623-32. PubMed ID: 1682818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
    Harsing LG; Vizi ES
    J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens.
    Hicks PE; Langer SZ; Macrae AD
    Br J Pharmacol; 1985 Sep; 86(1):141-50. PubMed ID: 2864967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-adrenoceptor blocking properties of vesamicol.
    Wannan G; Prior C; Marshall IG
    Eur J Pharmacol; 1991 Aug; 201(1):29-34. PubMed ID: 1686588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some pharmacological properties of Wy 27127 a more selective alpha 2:alpha 1-adrenoceptor antagonist than idazoxan in vitro.
    Bill SJ; Boniface A; Haroun F; McAdams RP; Lattimer N; Rhodes KF
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):418-22. PubMed ID: 2881217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
    Doxey JC; Lane AC; Roach AG; Virdee NK
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):136-44. PubMed ID: 6144048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification by desipramine of the effects of alpha-adrenoceptor antagonists on the contractile responses of the trisected rat vas deferens.
    Bradley L; Doggrell SA
    Gen Pharmacol; 1985; 16(5):475-82. PubMed ID: 2865190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat.
    Berridge TL; Doxey JC; Roach AG; Smith CF
    Eur J Pharmacol; 1992 Mar; 213(2):205-12. PubMed ID: 1355733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of dopamine D1 receptor on the sympathetic nerve endings in the guinea-pig vas deferens.
    Furukawa T; Morishita H
    Eur J Pharmacol; 1997 Jun; 328(2-3):229-34. PubMed ID: 9218705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Imidazolinyl-2)-2-benzodioxane 1-4 (idazoxan) and its stereoisomers, new alpha 2-antagonists.
    Dabiré H; Mouille P; Schmitt H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S127-9. PubMed ID: 2414573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of presynaptic alpha 1-adrenoceptors in the effects of idazoxan and prazosin on 3H-noradrenaline release from tail arteries of SHR.
    Hicks PE; Najar M; Vidal M; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):354-61. PubMed ID: 2877400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and desensitization of presynaptic alpha 2-adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferens.
    García-Sevilla JA; Zubieta JK
    Br J Pharmacol; 1986 Dec; 89(4):673-83. PubMed ID: 3028549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on receptor interaction for the alpha-antagonist WB 4101.
    Kapur H; Green PN; Mottram DR
    J Pharm Pharmacol; 1979 Mar; 31(3):188-9. PubMed ID: 34700
    [No Abstract]   [Full Text] [Related]  

  • 20. Two phases of contractile response in rat isolated vas deferens and their regulation by adenosine and alpha-receptors.
    Major TC; Weishaar RE; Taylor DG
    Eur J Pharmacol; 1989 Aug; 167(3):323-31. PubMed ID: 2572433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.